Document is current
Any future updates will be listed below
-
Authors
Mocchi, Madaline
Bartoli, Eleonora
Magnotti, John
de Gee, Jan Willem
Metzger, Brian
Pascuzzi, Bailey
Mathura, Raissa
Pulapaka, Suhruthaa
Goodman, Wayne
Sheth, Sameer
McGinley, Matthew J.
Bijanki, Kelly
-
Funding
Funding for this research was provided by:
National Institutes of Health (NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006, NIH R01-MH127006)
Wallace Foundation
- License Information
-
More Information
Article History
Received: 19 April 2024
Accepted: 22 November 2024
First Online: 28 December 2024
Declarations
:
: M.M. and K.B. are inventors of a planned patent on the electrophysiology measure of state (1/f activity reported in the current manuscript) as a biomarker for MDD and mood state. KB is an inventor of an issued patent on an unrelated method of electrical stimulation to treat depression, anxiety, and pain. SS has consulting agreements with Boston Scientific, Neuropace, Abbott, and Zimmer Biomet. WG has received donated devices from Medtronic and has consulting agreements with Biohaven Pharmaceuticals. All other authors do not have a conflict of interest.
